CLLS Cellectis S.A.
-
Cellectis S.A. Reported Earnings
Thursday, August 6, 2026 · 12:00 AM ET
Cellectis S.A. (CLLS) reported a loss of $0.22 per share on revenue of $6.90 million for the . . Revenue fell 62.05% compared to the same quarter a year ago.
Cellectis SA is a gene-editing company. The company focused on developing immunotherapies based on gene edited engineered CAR-T cells. Cellectis SA is based in Paris, France.
Earnings Whisper Grade
—
Power Rating—
Reported Earnings
($0.22)
Earnings Whisper®
—
Consensus Estimate
—
Earnings Surprise
Earnings Growth
Reported Revenue
$6.90M
Revenue Estimate
—
Revenue Surprise
Revenue Growth